Filter
1629
Text search:
Disease
Analyse
Featured
173
411
Language
Document type
741
288
268
133
108
38
33
10
4
3
2
1
Countries / Regions
106
50
49
39
35
34
34
32
24
21
21
20
20
19
19
19
18
17
15
15
15
14
14
13
13
12
12
12
11
11
10
9
9
8
7
7
7
7
7
7
6
6
6
6
5
5
5
4
4
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
541
125
124
122
69
34
21
Toolboxes
175
94
90
72
68
63
54
53
52
47
46
45
45
44
32
30
25
24
22
22
17
14
10
6
4
1
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
Copenhagen, Denmark, 24–25 August 2017
10–11 May 2016, Catania, Italy
Current Issüs Arising from Tuberculosis Screening with Interferon-Gamma- Release Assays (IGRAs)
Pneumologie 2015; 69: 271–275
Mission report: June 11-20, 2017
Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduction of VPDs is a significant aim of public-health
...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
This study examines over 20 years of CBR implementation in Nepal. It includes an overview of CBR interventions, provides analysis of approaches and activities in terms of impact and sustainability and makes recommendations for future developments in CBR. This resource is useful for people interested
...
